// App-Quantinova.ai

P531 : AN OBSERVATIONAL, MULTICENTER, RETROSPECTIVE ANALYSIS OF PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH TAGRAXOFUSP IN THE EUROPEAN EXPANDED ACCESS PROGRAM

Researchers

Presenter

  • Marco Herling

Principal Investigators

  • Eric Deconinck

  • Madhu Anant

  • David Manteigas

  • Marcello Riggi

  • Emanuele Angelucci

Medical Centers

  • Cmed,West Sussex,Regno Unito

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Hematology and Cellular Therapy Unit,IRCCS Ospedale Policlinico San Martino,Genova,Italie

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Cmed,West Sussex,Royaume-uni

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital,Leipzig,Allemagne

  • Hematology and Cellular Therapy Unit,IRCCS Ospedale Policlinico San Martino,Genova,Italie

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Regional University Hospital of Besançon,Besançon

  • Cmed,West Sussex,Verenigd Koninkrijk

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Hematology and Cellular Therapy Unit,IRCCS Ospedale Policlinico San Martino,Genova,Italie

  • Regional University Hospital of Besançon,Besançon

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Hematology and Cellular Therapy Unit,IRCCS O

  • Regional University Hospital of Besançon,Besançon

  • Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital,Leipzig,Allemagne

  • Cmed,West Sussex,Vereinigtes Königreich

  • Cmed,West Sussex,Regno Unito

  • Cmed,West Sussex,United Kingdom

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

  • Cmed,West Sussex,Соединённое Королевство

  • Cmed,West Sussex,Storbritannien

  • Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital,Leipzig,Allemagne

  • Regional University Hospital of Besançon,Besançon

  • Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital,Leipzig,Allemagne

  • Regional University Hospital of Besançon,Besançon

  • Hematology and Cellular Therapy Unit,IRCCS Ospedale Policlinico San Martino,Genova,Italie

  • Stemline Therapeutics Switzerland GmbH,Zug,Suisse

Locations

  • Germany

  • France

  • Switzerland

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Blastic plasmacytoid dendritic cell neoplasm

Biomarkers

  • Triglyceride Level

Drug/Treatment

  • Tagraxofusp

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved